Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018927 · ClinicalTrials.gov registry record
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
A clinical trial, sponsored by University of Arkansas.
- Terminated
- Registry status
- 44
- Enrollment target
NCT01018927 is a clinical trial that was terminated before completion, run by University of Arkansas. The registered enrollment target is 44 participants.
The verdict
NCT01018927 was terminated before completion, sponsored by University of Arkansas.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.
Interventions
- DEVICE Administering three additional MRI images
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018927
The ClinicalTrials.gov registry entry for NCT01018927 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Administering three additional MRI images is the first listed.
NCT01018927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018927 about?
NCT01018927 is a clinical study titled "Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects". The purpose of this study is to see if MRI techniques can be used for early evaluation of cardiac amyloidosis which is sometimes seen in individuals with multiple myeloma. Cardiac amyloidosis is a medical disorder that decreases heart function.
What is the current status of trial NCT01018927?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2009-06. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT01018927?
The interventions under investigation include: Administering three additional MRI images (DEVICE).
Who is sponsoring clinical trial NCT01018927?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.